Skip to content
Open access

Hexabromocyclododecane exposure induces cochlear hair cell damage via estrogen receptor α-mediated oxidative stress and autophagy dysfunction.

Nov 2026 · Ecotoxicology and Environmental Safety · Vol 327, pp. 121042 · 0 citations · 73 references
Medicine

Abstract

Hexabromocyclododecane (HBCD) is a persistent brominated flame retardant with known neurotoxic and endocrine-disrupting effects, yet its ototoxicity remains unclear. This study utilized HEI-OC1 cells and C57BL/6 mice exposed to HBCD by oral gavage at 50 mg/kg/day for 28 days to evaluate HBCD ototoxicity and its underlying mechanisms. HBCD exposure (0-100 μM) reduced cell viability dose-dependently (IC50 = 35.22 μM) and significantly downregulated estrogen receptor alpha (ERα) protein expression. Transcriptomic analysis revealed alterations in estrogen signaling, oxidative stress, and autophagy-related pathways. Mechanistically, HBCD induced mitochondrial dysfunction, evidenced by loss of membrane potential, altered MitoTracker fluorescence, and elevated mitochondrial and intracellular reactive oxygen species (ROS) levels. Concurrently, increased LC3B-Ⅱ and phospho-p62 levels indicated autophagosome accumulation as a result of impaired autophagic flux. Co-treatment with the ERα agonist 17β-estradiol (E2) or antioxidant N-acetylcysteine (NAC) partially alleviated ROS accumulation and autophagic dysregulation, respectively. Notably, the autophagy inhibitor 3-methyladenine (3-MA) significantly reduced HBCD-induced cell death. In vivo, HBCD-exposed mice exhibited cochlear hair cell damage and disorganization of the organ of Corti, accompanied by altered expression of autophagy-related proteins in cochlear tissues, changes that were partially reversed by 3-MA intervention. ABR thresholds were elevated at 4, 16, and 32 kHz and under click stimulation; co-treatment with 3-MA reduced thresholds at 4 and 16 kHz and under click stimulation. Collectively, these findings suggest that HBCD is associated with cochlear hair cell injury via ERα suppression, which may induce mitochondrial dysfunction and oxidative stress, leading to subsequent autophagic impairment. In vivo evidence further validates the pathological relevance of these mechanisms at the cochlear tissue level. This study provides mechanistic insights into HBCD's potential ototoxicity under high-risk exposure conditions and highlights ERα-associated pathways as promising therapeutic targets.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.